324 related articles for article (PubMed ID: 18591570)
1. Skin-sparing intensity-modulated radiotherapy of the breast.
Vordermark D
J Clin Oncol; 2008 Jul; 26(19):3292; author reply 3292-3. PubMed ID: 18591570
[No Abstract] [Full Text] [Related]
2. Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?
Haffty BG; Buchholz TA; McCormick B
J Clin Oncol; 2008 May; 26(13):2072-4. PubMed ID: 18285600
[No Abstract] [Full Text] [Related]
3. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
4. Skin-sparing intensity-modulated radiotherapy of the breast.
Bölke E; Matuschek C; Gripp S; Budach W; Gerber PA; Peiper M
J Clin Oncol; 2008 Nov; 26(32):5305-6; author reply 5306. PubMed ID: 18854555
[No Abstract] [Full Text] [Related]
5. More radiotherapy for radiation-induced second malignancies?
Formenti S
Breast Cancer Res Treat; 2010 Dec; 124(3):851-2. PubMed ID: 19763818
[No Abstract] [Full Text] [Related]
6. Breast conservation treatment with radiation: an ongoing success story.
Solin LJ
J Clin Oncol; 2010 Feb; 28(5):709-11. PubMed ID: 20048173
[No Abstract] [Full Text] [Related]
7. Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.
Taunk NK; Haffty BG; Goyal S
J Clin Oncol; 2011 Aug; 29(22):e661-3. PubMed ID: 21646611
[No Abstract] [Full Text] [Related]
8. Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation.
Yamazaki H; Yoshida K; Nishimura T; Kobayashi K; Tsubokura T; Kodani N; Aibe N; Nishimura T
J Radiat Res; 2011; 52(4):496-501. PubMed ID: 21905308
[No Abstract] [Full Text] [Related]
9. Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer.
Sharp L; Johansson H; Hatschek T; Bergenmar M
Breast; 2013 Oct; 22(5):634-8. PubMed ID: 23953136
[TBL] [Abstract][Full Text] [Related]
10. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
11. A papule arising in irradiated breast tissue.
Lowe J; Lu D; Heffernan MP
Arch Dermatol; 2006 Jan; 142(1):101-6. PubMed ID: 16415395
[No Abstract] [Full Text] [Related]
12. [Prevention and therapy of radiodermatitis in postoperative radiotherapy following mastectomy].
Kastratović M; Rödl W
Fortschr Med; 1971 Aug; 89(22):889-90. PubMed ID: 5154177
[No Abstract] [Full Text] [Related]
13. Predictors for clinical outcomes after accelerated partial breast intensity-modulated radiotherapy.
Reeder R; Carter DL; Howell K; Henkenberns P; Tallhamer M; Johnson T; Kercher J; Widner J; Kaske T; Paul D; Sedlacek S; Leonard CE
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):92-7. PubMed ID: 18786783
[TBL] [Abstract][Full Text] [Related]
14. [Acute skin toxicity in breast intensity modulated radiotherapy using field in field technique].
Blanchecotte J; Ruffier-Loubière A; Reynaud-Bougnoux A; Barillot I
Cancer Radiother; 2015 Apr; 19(2):82-8. PubMed ID: 25623257
[TBL] [Abstract][Full Text] [Related]
15. A clinico-dosimetric characteristic of radiotherapy in patients with early stages of breast cancer.
Megali Y; Mikhina ZP; Gorlachev GE; Gutnik RA; Ivanov VN; Pirogova NA
Saudi Med J; 2000 Apr; 21(4):400-1. PubMed ID: 11533832
[No Abstract] [Full Text] [Related]
16. Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
Koukourakis MI; Tsoutsou PG; Abatzoglou IM; Sismanidou K; Giatromanolaki A; Sivridis E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1173-80. PubMed ID: 19058920
[TBL] [Abstract][Full Text] [Related]
17. Relationships among patient characteristics, irradiation treatment planning parameters, and treatment toxicity of acute radiation dermatitis after breast hybrid intensity modulation radiation therapy.
Lee TF; Sung KC; Chao PJ; Huang YJ; Lan JH; Wu HY; Chang L; Ting HM
PLoS One; 2018; 13(7):e0200192. PubMed ID: 30011291
[TBL] [Abstract][Full Text] [Related]
18. Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin.
Gzell CE; Carroll SL; Suchowerska N; Beith J; Tan K; Scolyer RA
Cancer Invest; 2009 May; 27(4):397-401. PubMed ID: 19219651
[TBL] [Abstract][Full Text] [Related]
19. Lung carcinoma development after radiotherapy for breast carcinoma.
Buchholz TA
Cancer; 2003 Oct; 98(7):1331-3. PubMed ID: 14508817
[No Abstract] [Full Text] [Related]
20. Radiotherapy for early stage favourable breast cancers.
Buchholz TA; Singletary SE
Br J Cancer; 2002 Jan; 86(2):309-11. PubMed ID: 11870524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
